GSE111247 temozolomide LN-308 0 v 7 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE111247_temozolomide_LN-308_0_v_7_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE111247_temozolomide_LN-308_0_v_7_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE111247_temozolomide_LN-308_0_v_7_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE111247_temozolomide_LN-308_0_v_7_human_up.

Results found

Linked to

 

Label

Description

 

Gene

synergin gamma

Gene

non-coding RNA activated by DNA damage

Gene

CTA-216E10.6

Gene

long intergenic non-protein coding RNA 1138

Gene

HECW2 antisense RNA 1

Gene

hydroxysteroid 17-beta dehydrogenase 7 pseudogene 2

Gene

FSHD region gene 1 family member H, pseudogene

Gene

endogenous retrovirus group E member 5

Gene

SRP14 divergent transcript

Gene

FAM151B divergent transcript


  • Gene

    non-coding RNA activated by DNA damage



  • Gene

    long intergenic non-protein coding RNA 1138


  • Gene

    HECW2 antisense RNA 1


  • Gene

    hydroxysteroid 17-beta dehydrogenase 7 pseudogene 2


  • Gene

    FSHD region gene 1 family member H, pseudogene


  • Gene

    endogenous retrovirus group E member 5


  • Gene

    SRP14 divergent transcript


  • Gene

    FAM151B divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.